Clinical Trial Update: Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial update on bococizumab with an autoinjector in hyperlipidemia; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Bococizumab (bococizumab)

Snippet

Sponsor: Pfizer | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2017-12-19